Vaidehi Ambatipudi

Head of Strategy and Business Development
Rapid Micro Biosystems

Vaidehi is shrinking pharmaceutical quality testing from 14 days to 24 hours, reshaping what sustainable manufacturing looks like.

Vaidehi Ambatipudi brings a strong mix of strategy, business development, and technical understanding to the life sciences sector.

As Head of Strategy and Business Development at Rapid Micro Biosystems, she focuses on positioning and scaling technologies that improve pharmaceutical manufacturing.

The company’s rapid microbial detection technology reduces testing timelines significantly. This has implications not just for speed, but also for energy use and efficiency.

Vaidehi’s background spans Cytiva, Pall Biotech, Thermo Fisher Scientific, and Boston Consulting Group.

Her work connects strategic decisions with operational impact. It shows how business direction can directly influence sustainability outcomes in manufacturing. and how it is positioned have real consequences for how efficiently and responsibly medicines get made.

Found her interesting? Connect with Vaidehi on LinkedIn.

What I’d love to discuss during the event

  • We’re cutting pharmaceutical quality testing from 14 days to 24 hours. The sustainability implication is real — less waste, less energy, faster cycles. Why isn’t the industry moving faster on this?
  • Strategy in life sciences often gets disconnected from operations. Where does that disconnect cost the most — in sustainability terms?
  • What does it actually take to change a standard practice in pharmaceutical manufacturing that’s been the same for thirty years?
Area of Expertise
AnalyticsPlanningSemiconductorsSupply Chain

Ask a Question to Vaidehi Ambatipudi

The Boston Roundtable

Social
Certifications
Subscribe to Sprih's Newsletter and start leading the change.
© 2026 Sprih. All rights reserved.